Total planned funding: $396,613,381
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $83,429,110 |
Kenya | $81,537,480 |
Uganda | $36,893,969 |
Tanzania | $26,802,452 |
Ethiopia | $24,844,236 |
South Africa | $21,761,312 |
Zambia | $21,235,380 |
Malawi | $16,322,331 |
Côte d'Ivoire | $13,503,720 |
Haiti | $12,266,488 |
Eswatini | $10,514,522 |
Botswana | $9,814,042 |
South Sudan | $6,544,459 |
Angola | $6,453,000 |
Namibia | $4,125,947 |
Central Asia Region | $3,455,000 |
Central America Region | $3,156,907 |
Caribbean Region | $2,260,000 |
Lesotho | $2,243,723 |
Rwanda | $1,836,731 |
Vietnam | $1,744,700 |
Ukraine | $1,610,000 |
Burma | $1,000,000 |
India | $850,000 |
Cameroon | $631,572 |
Burundi | $500,000 |
Zimbabwe | $456,300 |
Nigeria | $450,000 |
Dominican Republic | $200,000 |
Ghana | $120,000 |
Asia Regional Program | $50,000 |
Democratic Republic of the Congo | $0 |
Organizational Types
University | $396,613,381 |
Program Areas
Treatment | $144,250,326 |
Prevention | $80,531,765 |
Care | $72,906,634 |
Governance and Systems | $63,933,709 |
Testing | $34,990,947 |
Budget Codes
HTXS: Treatment: Adult Treatment | $126,685,755 |
HBHC: Care: Adult Care and Support | $38,522,292 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $36,493,777 |
HVCT: Testing: HIV Testing and Counseling | $34,990,947 |
HVSI: Strategic Information | $33,685,286 |
OHSS: Health Systems Strengthening | $23,393,380 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $22,392,013 |
PDTX: Treatment: Pediatric Treatment | $17,564,571 |
HVOP: Sexual Prevention: Other Sexual Prevention | $17,511,270 |
HVTB: Care: TB/HIV | $13,786,938 |
HKID: Care: Orphans and Vulnerable Children | $10,820,676 |
PDCS: Care: Pediatric Care and Support | $9,776,728 |
HLAB: Laboratory Infrastructure | $6,855,043 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,019,665 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $944,760 |
HMIN: Biomedical Prevention: Injection Safety | $775,000 |
HMBL: Biomedical Prevention: Blood Safety | $395,280 |
HTXD: Treatment: ARV Drugs | $0 |